You are here

TAK-994

Takeda reports data from Phase II narcolepsy type 1 therapy trial

Clinical Trials Arena

Thu, 07/27/23 - 10:16 am

clinical trials

Takeda cuts ties to cancer drug landed in $120M Turnstone deal

Fierce Biotech

Thu, 07/28/22 - 10:59 am

Turnstone Biologics

Takeda halts trial of orexin drug in narcolepsy on safety grounds

Pharmaforum

Wed, 10/6/21 - 10:52 am

clinical trials